openPR Logo
Press release

EMEA (Europe, Middle East and Africa) Marine Collagen Peptide Market Report 2017

08-29-2017 04:10 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Marine Collagen Peptide

EMEA (Europe, Middle East and Africa) Marine Collagen Peptide Market Report 2017

EMEA (Europe, Middle East and Africa) Marine Collagen Peptide Market Report 2017

The EMEA (Europe, Middle East and Africa) Marine Collagen Peptide Market Report 2017 is a professional and in-depth study on the current state of the Marine Collagen Peptide industry.

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Marine Collagen Peptide market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Marine Collagen Peptide industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

In this report, the EMEA Marine Collagen Peptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Marine Collagen Peptide for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Marine Collagen Peptide market competition by top manufacturers/players, with Marine Collagen Peptide sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Rousselot
    Gelita AG
    Darling Ingredients
    PB Gelatins/PB Leiner
    Vital Proteins
    Lapi Gelatine
    Nippi Collagen
    Wellnex
    Nitta Gelatin
    Amicogen, Inc
    ChinaPeptides

...

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Pharmaceutical Grade
    Food Grade
    Industrial Grade

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Marine Collagen Peptide for each application, including
    Bone and Joint Health
    Pharmaceuticals
    Cosmeceuticals
    Nutraceuticals
    Pet Food
    Food and Beverages
    Others

To get a free professional report sample, please email to tinaning@qyresearch.com or Browse our detailed product page: https://www.qyresearcheurope.com/goods-694614.html

Table of contents:

1 Marine Collagen Peptide Overview

2 EMEA Marine Collagen Peptide Competition by Manufacturers/Players/Suppliers, Region, Type and Application

3 Europe Marine Collagen Peptide (Volume, Value and Sales Price), by Players, Countries, Type and Application

4 Middle East Marine Collagen Peptide (Volume, Value and Sales Price), by Region, Type and Application

5 Africa Marine Collagen Peptide (Volume, Value and Sales Price) by Players, Countries, Type and Application

6 EMEA Marine Collagen Peptide Manufacturers/Players Profiles and Sales Data

7 Marine Collagen Peptide Manufacturing Cost Analysis

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

10 Market Effect Factors Analysis

11 EMEA Marine Collagen Peptide Market Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

List of Tables and Figures
    Figure Product Picture of Marine Collagen Peptide
    Figure EMEA Marine Collagen Peptide Sales Volume (K MT) by Type (2012-2022)
    Figure EMEA Marine Collagen Peptide Sales Volume Market Share by Type (Product Category) in 2016
    Figure Pharmaceutical Grade Product Picture
    Figure Food Grade Product Picture
    Figure Industrial Grade Product Picture
    Figure EMEA Marine Collagen Peptide Sales Volume (K MT) by Application (2012-2022)
    Figure EMEA Sales Market Share of Marine Collagen Peptide by Application in 2016
    Figure Bone and Joint Health Examples
    Table Key Downstream Customer in Bone and Joint Health
    Figure Pharmaceuticals Examples

......

Related Reports:

Global Marine Collagen Peptide Market Report 2017

China Marine Collagen Peptide Market Report 2017

USA Marine Collagen Peptide Market Report 2017

Korea Marine Collagen Peptide Market Report 2017

Japan Marine Collagen Peptide Market Report 2017

India Marine Collagen Peptide Market Report 2017

Contact Details:

Tina| Sales Managers

Company Name: QYResearch CO.,LIMITED  | focus on Market Survey and Research

Email: tinaning@qyresearch.com Tel: 0086-20-22093278(CN)

Web: http://www.qyresearchglobal.com/

QYResearch established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc industries experts who own more than 10 years experiences on marketing or R&D), professional survey team (the team member with more than 3 years market survey experience and more than 2 years depth expert interview experience),Excellent data analysis team (SPSS statistics and PPT graphics process team); QYResearch has always pursuit product quality, adhere to the quality is the soul of business.

Room 2311 VILI International Building No.167 Linhe West Road Tianhe District

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release EMEA (Europe, Middle East and Africa) Marine Collagen Peptide Market Report 2017 here

News-ID: 687725 • Views:

More Releases for Peptide 

Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be? In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: • Global Peptide Cancer Drug Market Insight By Region & Indication • Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion • Approved Peptide Cancer Drugs: > 30 Drugs • Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis • Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase • Insight On Peptide Cancer Drugs In Clinical Trials: >
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). [https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established